Inactive Instrument

BIO-TECHNE Corp Stock Nasdaq

Equities

US8783771004

Biotechnology & Medical Research

End-of-day quote Nasdaq
- USD - Intraday chart for BIO-TECHNE Corp
Sales 2024 * 1.15B Sales 2025 * 1.25B Capitalization 10.01B
Net income 2024 * 179M Net income 2025 * 229M EV / Sales 2024 * 8.9 x
Net Debt 2024 * 187M Net cash position 2025 * 10.85M EV / Sales 2025 * 8.03 x
P/E ratio 2024 *
57.4 x
P/E ratio 2025 *
44.9 x
Employees -
Yield 2024 *
0.5%
Yield 2025 *
0.5%
Free-Float 99.02%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 57 18-04-29
Director of Finance/CFO 53 14-03-31
Chief Operating Officer 55 Jan. 07
Members of the board TitleAgeSince
Chairman 68 02-12-31
Director/Board Member 74 89-12-31
Director/Board Member 71 17-10-25
More insiders
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools (74.3%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (25.7%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. Net sales are distributed geographically as follows: the United States (56.5%), the United Kingdom (4.4%), Europe/Middle East/Africa (19.4%), China (10%), Asia/Pacific (6.4%), and other (3.3%).
Calendar
Related indices
More about the company